Clinical trial
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
NCT00004186
Study timeline
Study start (unknown)1996-12-01Date precision: month
Registry last updated2013-04-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
carboplatinDRUG · verified · RxNorm: carboplatin
etoposideDRUG · verified · RxNorm: etoposide
ifosfamideDRUG · verified · RxNorm: ifosfamide
topotecan hydrochlorideDRUG · verified · RxNorm: topotecan hydrochloride
radiation therapyRADIATION
Sponsors & collaborators
University of Alabama at Birminghamlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00004186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.